CDRI-85/287 elicited a dose-dependent increase in the Bax/Bcl2 ratio, reaching upto 15-fold (p<0.001) and 9-fold (p<0.001) at IC50 concentration in MDA-MB231 and primary cancer cells respectively, thus mediating induction of apoptosis via intrinsic pathway. This evidence concerns the gene BAX and cancer.